Susquehanna International Group’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$264K Buy
35,912
+18,981
+112% +$140K ﹤0.01% 5208
2025
Q1
$131K Buy
+16,931
New +$131K ﹤0.01% 5742
2023
Q4
Sell
-2,823
Closed -$20.4K 6216
2023
Q3
$20.4K Sell
2,823
-847
-23% -$6.13K ﹤0.01% 5266
2023
Q2
$19.4K Sell
3,670
-213
-5% -$1.12K ﹤0.01% 5363
2023
Q1
$12.1K Buy
+3,883
New +$12.1K ﹤0.01% 5700
2022
Q4
Hold
0
6226
2022
Q3
Sell
-3,382
Closed -$45K 6444
2022
Q2
$45K Sell
3,382
-2,583
-43% -$34.4K ﹤0.01% 5262
2022
Q1
$30K Buy
5,965
+508
+9% +$2.56K ﹤0.01% 5410
2021
Q4
$38K Buy
+5,457
New +$38K ﹤0.01% 5534
2021
Q3
Sell
-7,363
Closed -$239K 5629
2021
Q2
$239K Buy
7,363
+2,692
+58% +$87.4K ﹤0.01% 4675
2021
Q1
$177K Buy
4,671
+3,048
+188% +$115K ﹤0.01% 4839
2020
Q4
$77K Buy
+1,623
New +$77K ﹤0.01% 4547
2020
Q3
Sell
-6,247
Closed -$275K 4635
2020
Q2
$275K Buy
6,247
+2,609
+72% +$115K ﹤0.01% 3451
2020
Q1
$119K Sell
3,638
-2,509
-41% -$82.1K ﹤0.01% 4000
2019
Q4
$314K Buy
6,147
+2,523
+70% +$129K ﹤0.01% 3099
2019
Q3
$133K Sell
3,624
-6,589
-65% -$242K ﹤0.01% 4001
2019
Q2
$565K Buy
+10,213
New +$565K ﹤0.01% 2791
2019
Q1
Sell
-2,083
Closed -$123K 3648
2018
Q4
$123K Sell
2,083
-14,212
-87% -$839K ﹤0.01% 3127
2018
Q3
$1.32M Buy
16,295
+1,250
+8% +$101K ﹤0.01% 1243
2018
Q2
$1.32M Buy
15,045
+2,848
+23% +$249K ﹤0.01% 1309
2018
Q1
$2.36M Buy
+12,197
New +$2.36M ﹤0.01% 855
2017
Q2
Hold
0
3839
2017
Q1
Sell
-209
Closed -$15K 3722
2016
Q4
$15K Buy
+209
New +$15K ﹤0.01% 4074
2016
Q2
Hold
0
3540
2016
Q1
Hold
0
4071
2015
Q4
Hold
0
4360
2015
Q3
Hold
0
4286
2015
Q2
Hold
0
4564
2015
Q1
Hold
0
4253
2014
Q4
Sell
-87
Closed -$173K 4483
2014
Q3
$173K Buy
87
+60
+222% +$119K ﹤0.01% 3583
2014
Q2
$95K Buy
+27
New +$95K ﹤0.01% 4034
2014
Q1
Sell
-31
Closed -$102K 3725
2013
Q4
$102K Buy
+31
New +$102K ﹤0.01% 3719
2013
Q3
Sell
-149
Closed -$501K 3621
2013
Q2
$501K Buy
+149
New +$501K ﹤0.01% 2513